Elsevier

Annals of Oncology

Volume 31, Supplement 4, September 2020, Pages S1192-S1193
Annals of Oncology

LBA8_PR Pembrolizumab plus chemotherapy versus chemotherapy as first-line therapy in patients with advanced esophageal cancer: The phase 3 KEYNOTE-590 study

https://doi.org/10.1016/j.annonc.2020.08.2298Get rights and content
Under an Elsevier user license
open archive

Cited by (0)